SASaima Ahmad

Saima Ahmad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Saima Ahmad has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Recurrent Reversible Carotid Dissection in Antiphospholipid Syndrome: A Case Report and Systematic Review of Vasculopathic Mechanisms

    by Muhammad Athar Javed, Saima Ahmad, Naila Amjad Cheema, Nida Pervaiz

    Antiphospholipid syndrome (APS) is increasingly recognized as a potential cause of cervical artery dissection, although the association remains underreported and poorly understood. We present a rare case of recurrent reversible internal carotid artery dissection in a patient with APS and systematically review current evidence regarding the pathophysiological mechanisms, clinical presentations, and management approaches. Our findings suggest that APS-related vasculopathy may predispose to arterial wall fragility and dissection through multiple mechanisms, including endothelial dysfunction, hypercoagulability, and altered vascular remodeling. Importantly, APS-associated dissections may demonstrate a higher potential for reversibility and recurrence compared to dissections of other etiologies, likely reflecting the dynamic nature of immune-mediated vascular injury rather than traditional atherosclerotic or traumatic causes. Recognizing this distinct entity is critical for appropriate management and prevention strategies in this population.

  • Open Access

    Epidemiology of Stroke and Risk Factors in Punjab, Pakistan: A Comprehensive Hospital-Based Study

    by Saima Ahmad, Adnan Khan, Fatima Gul Chaudhary, Haseeb Manzoor, Hira Jamil, Kausar Tayyab, Uchechukwu Levi Osuagwu

    Background: Stroke is a significant global health challenge, particularly burdening low- and middle-income countries where it leads to substantial mortality and disability-adjusted life years. Over the past four decades, these regions have witnessed a disturbing rise in stroke incidence. In Pakistan, the prevalence of stroke is of utmost public health concern, yet the absence of comprehensive epidemiological data obscures its true impact. Method: This retrospective hospital-based study was conducted at a Tertiary Care Hospital in Lahore, Punjab, Pakistan, serving as the primary referral center for stroke cases. Medical records from January 2019 to December 2020 were reviewed using the International Classification of Diseases. A structured data collection form captured demographics, stroke types, risk factors, medical histories, and outcomes. Results: Among 159,824 emergency department visits, 1654 patients were diagnosed with stroke, yielding an incidence rate of 1.03% in Punjab. The majority (26.13%) of stroke patients were aged 60-69 years, with an average age of 57.19 years. Males (51.75%) showed higher susceptibility than females (48.25%). A significant proportion (62.39%) of cases resulted in discharge with disability. Ischemic stroke was predominant (44.2%), followed closely by hemorrhagic stroke (43.4%). Hypertension (61.63%), diabetes (17.65%), and heart disease (8.73%) emerged as prevalent comorbidities. Lahore was the primary location for a substantial number of cases (46.3%). Conclusion: The high incidence of stroke (1.03%) in Punjab underscores urgent public health needs. Our study highlights prevalent risk factors such as hypertension, diabetes, and ischemic heart disease, emphasizing the necessity for targeted prevention strategies. Comprehensive epidemiological studies are crucial to accurately quantify stroke burden in Pakistan and implement effective interventions.


  • Open Access

    Quality of Life, Psychological Stress, and Cognitive Decline Post-Ruptured Anterior Communicating Artery Aneurysm Endovascular Treatment

    by Saima Ahmad, Hira Jamil, Muhammad Ajmal Khan

    Objective: The study assessed depression, quality of life, and cognitive function in patients who underwent coiling for anterior communicating artery aneurysm rupture. Methods: A retrospective sample of patients with ruptured anterior communicating artery aneurysms treated at our facility were enrolled from the timeframe of August 2018 and October 2021. This research includes 60 individuals who had coil treatment in total. They all finished the QoL and cognitive follow-up surveys. The core aim of the questionnaire was to evaluate each participant's cognitive impairments and depressive symptoms. To determine baseline clinical state, retrospective reviews of patient charts were conducted along with demographics, postoperative course, and specifics of endovascular coiling. Results: There were 22 females and 38 males. The presentation lasted anything from six months to three years, with most of it taking place in a single year. Of those who experienced post-coiling neurological impairments, 27% had none, and 73% had none. While 38% had no symptoms, 21% had mild depression, 20% had moderate depression, and 21% had severe depression symptoms. 62% of patients experienced depressive symptoms and a decline in cognition following therapy for ruptured ACoA aneurysms. Conclusion: Following therapy for ruptured AComA aneurysms, 62% of patients experienced cognitive deficits and depressive symptoms. The difficulties specific to aneurysms associated with AComA that result from injury to anterior brain areas such as the striatum, ventromedial prefrontal (orbitofrontal) cortex, or frontal cortex may be the source of these symptoms.


  • Open Access

    Peripheral Arteriovenous Malformation Embolization Using Squid

    by Saima Ahmad, Moeez Uddin

    Background and Objectives. Head and neck arteriovenous malformations and fistulae treatment without reflux and with nidal penetration can pose a particular challenge to the interventional radiologist. Squid, an ethylene-vinyl alcohol copolymer-based liquid embolic agent, was developed primarily for neuroradiologic interventions with limited applicability being described in the management of peripheral arteriovenous malformations. We present a study evaluating the safety and efficacy of using squid (18 and 12) alone and in combination with other embolic agents for peripheral arteriovenous malformation embolization in a cohort of adult and paediatric patients. Materials and Methods. Between January 2018 and December 2020, twenty patients (7 men and 13 women) with peripheral high-flow arteriovenous malformations who were treated primarily with arterial embolization using squid were retrospectively included. Anatomical sites being treated included the head and neck (16), extremities (2), uterus (1), and pelvis (1). Squid was used as the sole embolic agent in 15 patients, and transarterial embolization was employed in all cases except one where direct puncture embolization was used. Treatments were delivered over one or two sessions, with or without surgery. A total of 27 sessions were carried out with an interval time ranging from 6 to 36 months between sessions. Results. Technical success was achieved in all cases. In those patients treated with squid alone, 13 exhibited total devascularization following embolization, and a further 4 required surgical excision to achieve complete obliteration of the arteriovenous malformation. There were no major complications, cases of microcatheter entrapment, or dimethyl sulfoxide-related pain recorded. On follow-up, one patient reported persistent pain, and another patient developed a garlicky taste. All other patients reported complete resolution of symptoms following treatment. Conclusion. This study demonstrates the successful use of squid in managing peripheral arteriovenous malformations with low complication rates and long-term stable results, therefore validating its efficacy when used alone or in combination with other embolic agents. Squid may be the preferred embolic agent in any interventional radiologists armamentarium as it offers formulations with varying viscosities (squid-18 and squid-12). We conclude that squid should be considered as a first-line embolic agent in the management of peripheral arteriovenous malformations.


  • Open Access

    Transarterial Embolization of Intracranial Arteriovenous Fistulas with Large Venous Pouches in the Form of Venous Outlet Ectasia and Large Venous Varix or Aneurysm : Two Centers Experience

    by Mohamed Adel Deniwar, Saima Ahmad, Ashraf Ezz Eldin

    Objective : There are different types of cerebral vascular malformations. Pial arteriovenous fistulas (PAVFs) and dural arteriovenous fistulas (DAVFs) are two entities; they consist of one or more arterial connections to a single venous outlet without a true intervening nidus. The high turbulent flow of PAVFs and aggressive DAVFs with cortical venous reflux can result in venous outflow varix and aneurysmal dilatation. They pose a significant challenge to transvenous embolization (TVE), stereotactic radiosurgery, and surgical treatment. We aim to share our centers’ experience with the transarterial embolization (TAE) for arteriovenous fistulas (AVFs) with large venous pouches and to report the outcome.Methods : The authors’ two institutions’ databases were retrospectively reviewed from February 2017 to February 2021. All patients with intracranial high flow PAVFs and aggressive DAVFs with venous outlet ectasia and large venous varix and were treated by TAE were included.Results : Fifteen patients harboring 11 DAVFs and four PAVFs met our inclusion criteria. All patients underwent TAE in 17 sessions. Complete angiographic obliteration was achieved after 14 sessions in 12 patients (80%). Four patients (25%) had residual after one TAE session. Technical failure was documented in one patient (6.7%). Fourteen patients (93.3%) had favorable functional outcome (modified Rankin score 0–2).Conclusions : TAE for high flow or aggressive intracranial AVFs is a safe and considerable treatment option, especially for those associated with large venous pouches that are challenging and relatively high-risk for TVE.


  • Open Access

    Endovascular Management of Auricular Arteriovenous Malformations

    by Saima Ahmad

    This is a retrospective review of eight patients with extracranial arteriovenous malformations (AVMs) of the auricular region. All cases presented with significant hemorrhages or cosmetic defects. Highflow AVMs of the auricular are quite rare in contrast to low flow vascular lesions of the head and neck, making early diagnosis and treatment critical as incidences of recurrence are high if not managed properly. The purpose of this study is to present our experience of experimental endovascular treatment in a series of eight patients with auricular AVMs. From January 2015 to December 2017, eight patients with auricular AVM were put through transcatheter arterial embolization and percutaneous direct puncture embolization with polyvinyl alcohol (PVA) and bleomycin in five patients, glue embolization in one patient and coiling along with PVA in two patients to occlude high-flow fistula. Clinical outcomes were obtained through physical examination, and symptoms and a degree of devascularization on follow-up angiography. We performed 10 therapeutic embolization procedures. Of these, 3 resulted in absolute devascularization while 5 resulted in 75% obstruction. In 5 patient's embolization was performed as a palliative procedure. The other 3 were embolized as a sole mean of treatment for occluding the AVM. Only two patients developed postembolization necrosis and infection, and there has been no reexpansion of lesions to date. While thus far only having been used as percutaneous local sclerotherapy, this study found that bleomycin and PVA mixture, if used intraarterially can be more effective in the management of auricular AVM's.

  • Open Access

    Clinical outcome of endovascular coil embolization for cerebral aneurysms in Asian population in relation to risk factors: a 3-year retrospective analysis

    by Saima Ahmad

    Background: Long term results of endovascular coiling are yet scarce. This study reviews the impact of comorbidities on the success of endovascular coiling of both ruptured and unruptured intracranial aneurysms. Endovascular treatment has become thetreatment of choice after the ISAT trials. Independent risk factors that influence recovery are age, sex, smoking, and hypertension. Methods: This is a 3-year retrospective analysis, performed to assess the clinical and radiological outcome of patients with cerebral aneurysms treated with detachable coils in an Asian population with relation to comorbidities including smoking and hypertension with age and gender as mediators. From July 2015 to August 2018, a total of 297 consecutive patients (mean age: 45.5 years) with cerebral aneurysms both ruptured and unruptured who were treated at a single center with endovascular coiling procedures are included in the study. Clinical information and radiological outcomes were evaluated on regular follow-ups and telephonic interviews. A modified Rankin Scale was used to measure the clinical outcomes in patients. Results: We have found that smoking harmed clinical outcome, with smokers 35% less likely to recover, while hypertension played a smaller role with only 15%. It was found that while aneurysms are more prevalent in women than men, women not only have a higher chance of getting an aneurysm but also have poorer outcomes. Similarly, patients who were above the age of 40 had a lower chance of recovery compared to younger patients due to comorbidities irrespective of gender. Conclusion: Asian sub-continent has different genetic markers that lead to poorer outcomes of aneurysms in women, while outcomes are similar in men and women in developed nations. Smoking does not play a major role in women’s recovery. Men with comorbidity seemed to be at higher risk and age played a major role in their recovery.